JNH Ato-Care Super Barried ATO-Serum

Manufacturer: Daeduck Lab Co., Ltd
Effective date: 2012-08-24
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-05-31 22:32:53

Label at a glance#

ProductJNH Ato-Care Super Barried ATO-Serum

Active ingredientCERAMIDE 3

Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

ceramide 3

INACTIVE INGREDIENT SECTION

- Water - Cholesterol - Caprylic/Capric Triglyceride - Magnesium Aspartate - Zinc Gluconate - Portulaca Oleracea Extract – Phytosphingosine - Hydrogenated Lecithin - Oleic Acid - Stearic Acid - Butylene Glycol – Betaine - Lactic Acid - Copper Gluconate - Sodium PCA - Hamamelis Virginiana (Witch Hazel) Leaf Extract - Chamaecyparis Obtusa Oil - Sorbitol - Serine – Glycine - Glutamic Acid - Alanine - Lysine - Arginine - Threonine - Proline - Sodium Hydroxide - Phenoxyethanol - Methylparaben - Propylparaben - Ethylparaben - Isobutylparaben - Butylparaben

OTC - PURPOSE SECTION

moisturizer for atopic skin

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

keep out of reach of the children

INDICATIONS & USAGE SECTION

- Clean your skin first and apply the suitable amount of ATO serum, smoothly tap with fingers.
- After taking a shower or washing your face, dry up water first then put the Serum where you feel dry or itchy.
- If you ever feel dryness or sensitiveness from your skin, apply the Serum with controlling the amount.

WARNINGS SECTION

When using this product
- keep out of eyes, ears, and mouth. If contact occurs, rinse with plenty of cold water right away and contact a physician. If swallowing, drink plenty of water and contact a physician

DOSAGE & ADMINISTRATION SECTION

for external use only

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d1c9d1af-bddd-448d-86f7-69052b7d5b47	Product name	1	20220627
f52be47f-7aa7-46c0-b1fa-50c18dd50206	Product name	1	20201029
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
1681bc73-b05f-12c3-1075-382ae39f449c	Product name	1	20140508
597b1cfd-7b31-5048-62be-ca5cd740da2f	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
53010-3001-1	2019-11-13	C162847	48780-1	97449f38-d061-f6ea-e053-dbdaa90aa703	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
53010-3001-1	JNH Ato-Care Super Barried ATO-Serum	50 mL in 1 TUBE	LIQUID	50		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
53010-3001	JNH ATO-CARE SUPER BARRIED ATO-SERUM (CERAMIDE 3) LIQUID [DAEDUCK LAB CO., LTD]	1	Legacy NDC, 1 package rows	20120828_dfcfea55-bc0e-4c9d-a519-96d4076546e5.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
CERAMIDE 3	ACTIVE INGREDIENT	4370DF050B	1
CERAMIDE 3	ACTIVE MOIETY	4370DF050B	1
ALANINE	INACTIVE INGREDIENT	OF5P57N2ZX	1
ARGININE	INACTIVE INGREDIENT	94ZLA3W45F	1
BETAINE	INACTIVE INGREDIENT	3SCV180C9W	1
BUTYLENE GLYCOL	INACTIVE INGREDIENT	3XUS85K0RA	1
BUTYLPARABEN	INACTIVE INGREDIENT	3QPI1U3FV8	1
CHAMAECYPARIS OBTUSA WOOD OIL	INACTIVE INGREDIENT	P2OMP71Y62	1
CHOLESTEROL	INACTIVE INGREDIENT	97C5T2UQ7J	1
COPPER GLUCONATE	INACTIVE INGREDIENT	RV823G6G67	1
ETHYLPARABEN	INACTIVE INGREDIENT	14255EXE39	1
GLYCINE	INACTIVE INGREDIENT	TE7660XO1C	1
HYDROGENATED SOYBEAN LECITHIN	INACTIVE INGREDIENT	H1109Z9J4N	1
ISOBUTYLPARABEN	INACTIVE INGREDIENT	0QQJ25X58G	1
LACTIC ACID	INACTIVE INGREDIENT	33X04XA5AT	1
LYSINE	INACTIVE INGREDIENT	K3Z4F929H6	1
MAGNESIUM ASPARTATE	INACTIVE INGREDIENT	R17X820ROL	1
MEDIUM-CHAIN TRIGLYCERIDES	INACTIVE INGREDIENT	C9H2L21V7U	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	1
OLEIC ACID	INACTIVE INGREDIENT	2UMI9U37CP	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	1
PHYTOSPHINGOSINE	INACTIVE INGREDIENT	GIN46U9Q2Q	1
PORTULACA OLERACEA WHOLE	INACTIVE INGREDIENT	D5J3623SV2	1
PROLINE	INACTIVE INGREDIENT	9DLQ4CIU6V	1
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	1
SERINE	INACTIVE INGREDIENT	452VLY9402	1
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	1
SODIUM PYRROLIDONE CARBOXYLATE	INACTIVE INGREDIENT	469OTG57A2	1
SORBITOL	INACTIVE INGREDIENT	506T60A25R	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	1
THREONINE	INACTIVE INGREDIENT	2ZD004190S	1
WITCH HAZEL	INACTIVE INGREDIENT	101I4J0U34	1
ZINC GLUCONATE	INACTIVE INGREDIENT	U6WSN5SQ1Z	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 33 matching rows.

JNH Ato-Care Super Barried ATO-Serum
CERAMIDE 3
CHOLESTEROL
MEDIUM-CHAIN TRIGLYCERIDES
MAGNESIUM ASPARTATE
ZINC GLUCONATE
PORTULACA OLERACEA WHOLE
PHYTOSPHINGOSINE
HYDROGENATED SOYBEAN LECITHIN
OLEIC ACID
STEARIC ACID
BUTYLENE GLYCOL
BETAINE
LACTIC ACID
COPPER GLUCONATE
SODIUM PYRROLIDONE CARBOXYLATE
WITCH HAZEL
CHAMAECYPARIS OBTUSA WOOD OIL
SORBITOL
SERINE
GLYCINE
ALANINE
LYSINE
ARGININE
THREONINE
PROLINE
SODIUM HYDROXIDE
PHENOXYETHANOL
METHYLPARABEN
PROPYLPARABEN
ETHYLPARABEN
ISOBUTYLPARABEN
BUTYLPARABEN

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
53010-3001	53010-3001-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 32 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
CERAMIDE 3	4370DF050B	ACTIB
CHOLESTEROL	97C5T2UQ7J	IACT
MEDIUM-CHAIN TRIGLYCERIDES	C9H2L21V7U	IACT
MAGNESIUM ASPARTATE	R17X820ROL	IACT
ZINC GLUCONATE	U6WSN5SQ1Z	IACT
PORTULACA OLERACEA WHOLE	D5J3623SV2	IACT
PHYTOSPHINGOSINE	GIN46U9Q2Q	IACT
HYDROGENATED SOYBEAN LECITHIN	H1109Z9J4N	IACT
OLEIC ACID	2UMI9U37CP	IACT
STEARIC ACID	4ELV7Z65AP	IACT
BUTYLENE GLYCOL	3XUS85K0RA	IACT
BETAINE	3SCV180C9W	IACT
LACTIC ACID	33X04XA5AT	IACT
COPPER GLUCONATE	RV823G6G67	IACT
SODIUM PYRROLIDONE CARBOXYLATE	469OTG57A2	IACT
WITCH HAZEL	101I4J0U34	IACT
CHAMAECYPARIS OBTUSA WOOD OIL	P2OMP71Y62	IACT
SORBITOL	506T60A25R	IACT
SERINE	452VLY9402	IACT
GLYCINE	TE7660XO1C	IACT
ALANINE	OF5P57N2ZX	IACT
LYSINE	K3Z4F929H6	IACT
ARGININE	94ZLA3W45F	IACT
THREONINE	2ZD004190S	IACT
PROLINE	9DLQ4CIU6V	IACT
SODIUM HYDROXIDE	55X04QC32I	IACT
PHENOXYETHANOL	HIE492ZZ3T	IACT
METHYLPARABEN	A2I8C7HI9T	IACT
PROPYLPARABEN	Z8IX2SC1OH	IACT
ETHYLPARABEN	14255EXE39	IACT
ISOBUTYLPARABEN	0QQJ25X58G	IACT
BUTYLPARABEN	3QPI1U3FV8	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 9 · 521 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	DROPS / NASAL	26 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
BUTYLPARABEN	BUTYLPARABEN	3QPI1U3FV8	SUSPENSION / ORAL		12 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
SORBITOL	SORBITOL	506T60A25R	SUSPENSION / ORAL		45000 mg	Exact identifier — unii candidate 44 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	OINTMENT / TOPICAL		29 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
BUTYLENE GLYCOL	BUTYLENE GLYCOL	3XUS85K0RA	SYSTEM / TRANSDERMAL	8.12 mg		Exact identifier — unii candidate 2 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SUSPENSION/ DROPS / TOPICAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SOLUTION / TOPICAL		24 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
STEARIC ACID	STEARIC ACID	4ELV7Z65AP	OINTMENT / TOPICAL	15 %w/w		Exact identifier — unii candidate 26 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	INJECTION / SUBCUTANEOUS		2 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	GEL / TOPICAL		14 mg	Exact identifier — unii candidate 6 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / ORAL		9120 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
STEARIC ACID	STEARIC ACID	4ELV7Z65AP	TABLET / SUBLINGUAL	9 mg		Exact identifier — unii candidate 26 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTION, SOLUTION / INTRAVENOUS	0.42 %w/v		Exact identifier — unii candidate 20 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	TABLET, EXTENDED RELEASE / ORAL		13 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
SORBITOL	SORBITOL	506T60A25R	INJECTION / SUBCUTANEOUS	4.7 %w/v		Exact identifier — unii candidate 44 equally ranked IID candidates
SORBITOL	SORBITOL	506T60A25R	PASTE / DENTAL	14.6 %w/w		Exact identifier — unii candidate 44 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / EPIDURAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, FOR SOLUTION / INTRATHECAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	AEROSOL, FOAM / TOPICAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
LACTIC ACID	LACTIC ACID	33X04XA5AT	SUSPENSION / TOPICAL	0.7 %w/w		Exact identifier — unii candidate 18 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SUSPENSION / SUBCUTANEOUS	0.02 %w/v		Exact identifier — unii candidate 68 equally ranked IID candidates
ARGININE	ARGININE	94ZLA3W45F	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR		6240 mg	Exact identifier — unii candidate 11 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / NASAL	20 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SUSPENSION / ORAL	400 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	INJECTION, SUSPENSION / INTRAMUSCULAR	0.02 %w/v		Exact identifier — unii candidate 68 equally ranked IID candidates
HYDROGENATED SOYBEAN LECITHIN	HYDROGENATED SOYBEAN LECITHIN	H1109Z9J4N	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	213 mg		Exact identifier — unii candidate 4 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	CREAM / VAGINAL	0.19 %w/w		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRA-ARTERIAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SHAMPOO / TOPICAL	0.15 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
LACTIC ACID	LACTIC ACID	33X04XA5AT	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 18 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	0.8 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
STEARIC ACID	STEARIC ACID	4ELV7Z65AP	SOAP / TOPICAL	6 %w/w		Exact identifier — unii candidate 26 equally ranked IID candidates
THREONINE	THREONINE	2ZD004190S	INJECTION, SOLUTION / INTRAVENOUS	0.12 %w/v		Exact identifier — unii candidate 3 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	OINTMENT / TOPICAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	GRANULE, FOR SUSPENSION / ORAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
STEARIC ACID	STEARIC ACID	4ELV7Z65AP	AEROSOL, FOAM / TOPICAL	8 %w/w		Exact identifier — unii candidate 26 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS	NA		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRAPLEURAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / URETHRAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	GEL, METERED / TRANSDERMAL		350 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
CHOLESTEROL	CHOLESTEROL	97C5T2UQ7J	CREAM / TOPICAL	1 %w/w		Exact identifier — unii candidate 10 equally ranked IID candidates
ARGININE	ARGININE	94ZLA3W45F	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		6240 mg	Exact identifier — unii candidate 11 equally ranked IID candidates
LACTIC ACID	LACTIC ACID	33X04XA5AT	INJECTION, SOLUTION / INTRAVENOUS		87 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
LACTIC ACID	LACTIC ACID	33X04XA5AT	INJECTION / INTRAMUSCULAR	1.16 %w/v		Exact identifier — unii candidate 18 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SOLUTION, CONCENTRATE / ORAL	0.2 mg/1ml		Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	LIQUID / ORAL		162 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	0.4 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	OINTMENT / OPHTHALMIC	0.05 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / IRRIGATION	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / EPIDURAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRACARDIAC	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	TABLET, DELAYED RELEASE / ORAL		4 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SYRUP / ORAL		81 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS	200 mg		Exact identifier — unii candidate 20 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / SUBCUTANEOUS	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
BUTYLPARABEN	BUTYLPARABEN	3QPI1U3FV8	DROPS / ORAL	NA		Exact identifier — unii candidate 15 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	FILM, EXTENDED RELEASE / TRANSDERMAL	0.85 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRASYNOVIAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / INTRAMUSCULAR		95 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SUSPENSION/ DROPS / AURICULAR (OTIC)	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
4c7b2fdb-3890-443e-a3cf-5eac1e2d0266			dfcfea55-bc0e-4c9d-a519-96d4076546e5	2012-08-24	Warnings	Exact identifier spl id: 4c7b2fdb-3890-443e-a3cf-5eac1e2d0266 spl set id: dfcfea55-bc0e-4c9d-a519-96d4076546e5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.